Project Details
Description
The study objectives are to validate two newly developed measures:
1.) Barriers to Adherence Screener (BAS) assesses individual and systems-level barriers to aid in triaging patients into appropriate interventions and
2.) Adherence Barriers Questionnaires (ABQ) evaluates barriers related to Cystic Fibrosis treatments addressable by behavioral interventions (e.g. problem solving)
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/17 → 2/28/20 |
Funding
- Children's Hospital Boston (Agmt 06/26/17 // Agmt 06/26/17)
- Cystic Fibrosis Foundation Therapeutics, Inc. (Agmt 06/26/17 // Agmt 06/26/17)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.